Renhe Pharmacy Co.,Ltd (SHE:000650)

Market Cap	7.71B +4.7%
Revenue (ttm)	3.68B -3.7%
Net Income	369.28M -21.3%
EPS	0.26 -21.8%
Shares Out	1.38B
PE Ratio	21.18
Forward PE	n/a
Dividend	0.15 (2.72%)
Ex-Dividend Date	Jun 17, 2025

Volume	7,097,600
Average Volume	14,098,166
Open	5.56
Previous Close	5.57
Day's Range	5.46 - 5.56
52-Week Range	5.31 - 7.02
Beta	0.45
RSI	39.78
Earnings Date	Apr 24, 2026

About Renhe Pharmacy Co.,Ltd

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is based in Nanchang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 5,394
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000650

Financial Performance

In 2025, Renhe Pharmacy Co.,Ltd's revenue was 3.54 billion, a decrease of -13.21% compared to the previous year's 4.07 billion. Earnings were 393.21 million, a decrease of -18.41%.